Compound heterozygous deletions of <i>PMP22</i> causing severe Charcot‐Marie‐Tooth disease of the Dejerine‐Sottas disease phenotype

American Journal of Medical Genetics, Part A - Tập 146A Số 18 - Trang 2412-2416 - 2008
Khalid Al‐Thihli1, Teresa Rudkin, Nancy Carson, Chantal Poulin, Serge B. Melançon, Vazken M. Der Kaloustian
1F. Clarke Fraser Clinical Genetics Unit, Division of Medical Genetics, McGill University Health Centre/Montreal Children's Hospital, Montreal, Quebec, Canada.

Tóm tắt

AbstractDejerine‐Sottas disease (DSD) is a particular phenotype of the Charcot‐Marie‐Tooth (CMT) disease spectrum that is genetically heterogeneous. It represents a severe form of hypertrophic axonal and demyelinating neuropathy. Although it is predominantly inherited as an autosomal recessive condition, autosomal dominant inheritance has also been described. To date, the autosomal recessive forms of DSD are classified into several CMT type 4 (CMT4) subclasses based on allelic heterogeneity. We present a 7‐year‐old boy with a severe form of CMT disease consistent with the autosomal recessive phenotype of DSD. He was found to be a compound heterozygote for mutations in the PMP22 gene resulting in homozygous deletion of exons 2 and 3. The maternally inherited allele was the typical 1.5 Mb deletion involving PMP22 seen with hereditary neuropathy with liability to pressure palsy (HNPP). The paternally inherited allele was a deletion of exons 2 and 3. Both parents presented with a typical clinical picture of HNPP. To our knowledge, this is the first patient reported with large deletions involving both PMP22 alleles. Our patient has also developed severe gastroesophageal reflux disease (GERD), a clinical feature not previously reported with CMT or DSD. The correlation of the phenotype and the molecular defects observed in this patient may set a new subcategory in the classification of DSD. © 2008 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1007/BF00868518

10.1042/bj3420537

10.1212/01.WNL.0000125287.98456.23

10.1016/0092-8674(93)90058-X

10.1136/jmg.2004.022178

10.1001/archneur.1968.00470360025002

10.1016/S0887-8994(02)00630-6

10.1007/s004390050694

10.1086/377591

10.1007/s10048-004-0185-0

10.1111/j.1749-6632.1999.tb08596.x

10.1136/jnnp.2003.020107

10.1007/s10048-006-0030-8

10.1002/(SICI)1098-1004(200004)15:4<340::AID-HUMU6>3.0.CO;2-Y

10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A

10.1002/1531-8249(200001)47:1<101::AID-ANA16>3.0.CO;2-2

10.1212/WNL.46.4.1133

10.1002/mus.10197

10.1007/BF02339245

10.1038/ng1193-269

10.1093/nar/gnf056

10.1002/(SICI)1098-1004(1998)12:1<59::AID-HUMU9>3.0.CO;2-A

10.1093/brain/awh653

10.1016/S1388-2457(03)00159-7

10.1159/000112898

10.1016/S0960-8966(02)00025-1

10.1093/jnen/63.11.1167

10.1111/j.1749-6632.1999.tb08621.x

Thông tin
Thông tin xuất bản

American Journal of Medical Genetics, Part A

Tập 146A Số 18

2412-2416

Thông tin tác giả